Providing a general introduction to this fascinating subject, this book is aimed at those studying advanced undergraduate and postgraduate courses in medicinal chemistry.
Providing a general introduction to this fascinating subject, this book is aimed at those studying advanced undergraduate and postgraduate courses in medicinal chemistry.
Professor Hanson is Emeritus Professor of Chemistry at the University of Sussex.
Inhaltsangabe
Chapter 1: Introduction 1.1: Aims 1.2: The Classification of Drugs 1.3: Targets for the Medicinal Chemist 1.4: The Stages in the Development of a Drug 1.5: The Synthesis of a Drug 1.6: The History of Medicinal Chemistry Chapter 2: General Principles of Medicinal Chemistry 2.1: Aims 2.2: Administration and Absorption 2.3: The Gastrointestinal Tract 2.4: Other Routes of Administration 2.5: Physico-Chemical Measurements 2.6: Formulation 2.7: Drug Metabolism 2.8: Oxidation by Cytochrome P450s 2.9: The Hydroxylation of Aromatic Rings 2.10: The Hydroxylation of Aliphatic Systems 2.11: The Monoamine Oxidases 2.12: Other Phase One Changes 2.13: Phase Two Changes 2.14: Excretion 2.15: Pro-Drugs 2.16: Quantitative Structure: Activity Relationships 2.17: Hansch QSAR Analyses 2.18: Craig Plots and the Topliss Decision Tree 2.19: Drug: Receptor Interactions Chapter 3: Neurotransmitters as Targets 3.1: Aims 3.2: Introduction 3.3: The Nervous System 3.4: The Neurotransmitters 3.5: Cell-Surface Receptors 3.6: Ion-Channel-Linked Receptors 3.7: Kinase-Linked Receptors 3.8: G-Protein-Linked Receptors 3.9: Agonists and Antagonists 3.10: Acetylcholine 3.11: Neuromuscular Blocking Agents in Surgery 3.12: Muscarinic Agonists 3.13: Local Anaesthetics 3.14: Catecholamines as Neurotransmitters 3.15: The Adrenergic Receptors 3.16: a-Adrenergic Receptor Agonists 3.17: b-Adrenergic Receptor Agonists - The Developmentof Anti-Asthma Drugs 3.18: b1-Adrenergic Antagonists 'b-Blockers' 3.19: The Treatment of Hypertension Chapter 4 Medicinal Chemistry and the Central Nervous System 4.1: Aims 4.2: Introduction 4.3: The Treatment of Neurodegenerative Diseases 4.4: Dopamine Antagonists as Neuroleptic Agents 4.5: Serotonin as a Neurotransmitter 4.6: The Treatment of Depression 4.7: GABA as a Neurotransmitter 4.8: The Treatment of Epilepsy 4.9: Benzodiazepines as Anxiolytic Agents 4.10: Barbiturate Sleeping Tablets 4.11: Opioids as Analgesics Chapter 5: Local and Circulatory Hormone Targets 5.1: Aims 5.2: Introduction 5.3: Histamine as a Target 5.4: Histamine Antagonists in the Treatment of Peptic Ulcers 5.5: The Prostaglandins and Non-Steroidal Anti-Inflammatory Agents 5.6: The Development of Ibuprofen 5.7: The Mechanism of Action of Aspirin 5.8: Medicinal Uses of Prostaglandins 5.9: The Sterols and Steroid Hormones 5.10: The Biosynthesis of the Steroids 5.11: The Control of Cholesterol Biosynthesis 5.12: The Steroidal Anti-Inflammatory Agents 5.13: The Steroidal Oral Contraceptives 5.14: The Role of Nitric Oxide Chapter 6: Anti-infective Agents 6.1: Aims 6.2: Introduction 6.3: Bacterial Diseases 6.4: Antiseptics 6.5: The Sulfonamide Anti-Bacterial Agents 6.6: The Penicillins 6.7: Clavulanic Acid and the Inhibition of b-Lactamases 6.8: The Cephalosporins 6.9: The Mode of Action of the b-Lactam Antibiotics 6.10: Other Antibiotics 6.11: Synthetic Anti-Bacterial Agents 6.12: Anti-Viral Agents 6.13: The Inhibition of Nucleic Acid Biosynthesis 6.14: Inhibitors of Reverse Transcriptase 6.15: Neuraminidase Inhibitors 6.16: The Synthesis of Nucleoside Analogues 6.17: Anti-Fungal Agents 6.18: Ergosterol Biosynthesis Inhibitors 6.19: Other Anti-Fungal Agents 6.20: Parasitic Infections Chapter 7: Cancer Chemotherapy 7.1: Aims 7.2: Introduction 7.3: The Cell Cycle 7.4: Cancer Chemotherapy 7.5: Anti-Metabolites 7.6: Alkylating Agents 7.7: Intercalating Agents 7.8: Anti-Mitotic Agents 7.9: Interference with Selected Developmental Processes 7.10: Monoclonal Antibodies 7.11: Prostate Cancer Further Reading Glossary Subject Index
Chapter 1: Introduction 1.1: Aims 1.2: The Classification of Drugs 1.3: Targets for the Medicinal Chemist 1.4: The Stages in the Development of a Drug 1.5: The Synthesis of a Drug 1.6: The History of Medicinal Chemistry Chapter 2: General Principles of Medicinal Chemistry 2.1: Aims 2.2: Administration and Absorption 2.3: The Gastrointestinal Tract 2.4: Other Routes of Administration 2.5: Physico-Chemical Measurements 2.6: Formulation 2.7: Drug Metabolism 2.8: Oxidation by Cytochrome P450s 2.9: The Hydroxylation of Aromatic Rings 2.10: The Hydroxylation of Aliphatic Systems 2.11: The Monoamine Oxidases 2.12: Other Phase One Changes 2.13: Phase Two Changes 2.14: Excretion 2.15: Pro-Drugs 2.16: Quantitative Structure: Activity Relationships 2.17: Hansch QSAR Analyses 2.18: Craig Plots and the Topliss Decision Tree 2.19: Drug: Receptor Interactions Chapter 3: Neurotransmitters as Targets 3.1: Aims 3.2: Introduction 3.3: The Nervous System 3.4: The Neurotransmitters 3.5: Cell-Surface Receptors 3.6: Ion-Channel-Linked Receptors 3.7: Kinase-Linked Receptors 3.8: G-Protein-Linked Receptors 3.9: Agonists and Antagonists 3.10: Acetylcholine 3.11: Neuromuscular Blocking Agents in Surgery 3.12: Muscarinic Agonists 3.13: Local Anaesthetics 3.14: Catecholamines as Neurotransmitters 3.15: The Adrenergic Receptors 3.16: a-Adrenergic Receptor Agonists 3.17: b-Adrenergic Receptor Agonists - The Developmentof Anti-Asthma Drugs 3.18: b1-Adrenergic Antagonists 'b-Blockers' 3.19: The Treatment of Hypertension Chapter 4 Medicinal Chemistry and the Central Nervous System 4.1: Aims 4.2: Introduction 4.3: The Treatment of Neurodegenerative Diseases 4.4: Dopamine Antagonists as Neuroleptic Agents 4.5: Serotonin as a Neurotransmitter 4.6: The Treatment of Depression 4.7: GABA as a Neurotransmitter 4.8: The Treatment of Epilepsy 4.9: Benzodiazepines as Anxiolytic Agents 4.10: Barbiturate Sleeping Tablets 4.11: Opioids as Analgesics Chapter 5: Local and Circulatory Hormone Targets 5.1: Aims 5.2: Introduction 5.3: Histamine as a Target 5.4: Histamine Antagonists in the Treatment of Peptic Ulcers 5.5: The Prostaglandins and Non-Steroidal Anti-Inflammatory Agents 5.6: The Development of Ibuprofen 5.7: The Mechanism of Action of Aspirin 5.8: Medicinal Uses of Prostaglandins 5.9: The Sterols and Steroid Hormones 5.10: The Biosynthesis of the Steroids 5.11: The Control of Cholesterol Biosynthesis 5.12: The Steroidal Anti-Inflammatory Agents 5.13: The Steroidal Oral Contraceptives 5.14: The Role of Nitric Oxide Chapter 6: Anti-infective Agents 6.1: Aims 6.2: Introduction 6.3: Bacterial Diseases 6.4: Antiseptics 6.5: The Sulfonamide Anti-Bacterial Agents 6.6: The Penicillins 6.7: Clavulanic Acid and the Inhibition of b-Lactamases 6.8: The Cephalosporins 6.9: The Mode of Action of the b-Lactam Antibiotics 6.10: Other Antibiotics 6.11: Synthetic Anti-Bacterial Agents 6.12: Anti-Viral Agents 6.13: The Inhibition of Nucleic Acid Biosynthesis 6.14: Inhibitors of Reverse Transcriptase 6.15: Neuraminidase Inhibitors 6.16: The Synthesis of Nucleoside Analogues 6.17: Anti-Fungal Agents 6.18: Ergosterol Biosynthesis Inhibitors 6.19: Other Anti-Fungal Agents 6.20: Parasitic Infections Chapter 7: Cancer Chemotherapy 7.1: Aims 7.2: Introduction 7.3: The Cell Cycle 7.4: Cancer Chemotherapy 7.5: Anti-Metabolites 7.6: Alkylating Agents 7.7: Intercalating Agents 7.8: Anti-Mitotic Agents 7.9: Interference with Selected Developmental Processes 7.10: Monoclonal Antibodies 7.11: Prostate Cancer Further Reading Glossary Subject Index
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
